32 min listen
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
ratings:
Length:
23 minutes
Released:
Jan 17, 2023
Format:
Podcast episode
Description
In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those with possible cardiometabolic toxicities, including:Monitoring for cardiometabolic syndromes (eg, lipid panels, coronary artery calcification scores)Approaching antiretroviral-related weight gain in clinical practiceInterpreting results from RESPOND on cardiovascular risk with integrase strand transfer inhibitorsCollaborating with other specialties (eg, cardiologists, dietitians) to provide a multidisciplinary approach for managing comorbidities, including prevention and managementFaculty: Marta Boffito, MD, PhD, FRCPConsultant Physician/ProfessorHIV/ResearchChelsea and Westminster HospitalImperial College LondonLondon, United KingdomJens D. Lundgren, MD, DMScProfessorRigshospital, University of Copenhagen DirectorCentre of Excellence for Health, Immunity and Infection (CHIP)Rigshospital, University of CopenhagenCopenhagen, DenmarkLink to full program:http://bit.ly/3PM3nYeLink to downloadable slides: http://bit.ly/3WgYycz
Released:
Jan 17, 2023
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 11: In Part 11 of this ongoing COVID-19 series, listen to a brief update on the role of interferons in COVID-19 by Sharon R. Lewin AO, FRACP, PhD, FAHMS. by CCO Infectious Disease Podcast